Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein 170 pseudogene 1 (CEP170P1) is a transcribed pseudogene sharing high sequence similarity with the functional CEP170 gene. CEP170P1 does not encode a functional protein and is not considered a drug target. The locus includes a transcribed pseudogene and an upstream homologous region that is not transcribed. This distinguishes CEP170P1 from CEP170, which codes for a protein involved in microtubule organization and centrosome function. No relevant biological function, disease association, or involvement in drug interactions is reported for CEP170P1. It should not be considered a receptor, enzyme, or other druggable molecular entity. If you intended to target the functional centrosomal protein (CEP170), please clarify, as CEP170P1 is a pseudogene and not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein 170 pseudogene 1 (CEP170P1).